Veeva Systems Inc.
Rank #256HypergrowthVEEV · NYSE · Healthcare
Veeva Systems Inc. (VEEV) — Rank #256 by gross profitability (GP/assets 0.27) · ROE 12.2% · Piotroski F-Score 5 / 9.
As-of 2026-09-15 · CIK 0001393052 · all metrics point-in-time as of the filing date.
About
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
Show moreShow less
The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc.
was incorporated in 2007 and is headquartered in Pleasanton, California.
- Industry
- Health Information Services
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- January 31
- Website
- veeva.com
Price History
Company Snapshot
P/S is the primary valuation lens — earnings are reinvested, not available for P/E.
Market Cap
$44.04B
P/E (annual)
50.0
P/S (annual)
13.8
P/B
5.9
P/OCF (annual)
31.1
Shareholder Yield
-7.0%
Employees
7,928
Industry
Health Information Services
Exchange
NYSE
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
1/1 passGrowth
1/2 passTerry Smith quality gate
Passes 2/5 Terry Smith thresholds2 of 5 thresholds not computable from filed data.
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
Earnings bubble check
Current margins may be above sustainable levels — a P/E based on peak earnings can overstate cheapness.
Disclosure regression check
2 previously-disclosed line items are no longer reported. Worth checking the filing for why.
Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.
Profitability
Gross profitability (GP / assets)
0.27
Primary signal (Novy-Marx).
27th pctl of 38 SIC 7372 peers
Return on equity
12.2%
Gross margin
75.5%
65th pctl of 38 SIC 7372 peers
Revenue growth (YoY)
270.6%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
Earnings CAGR (3Y)
23.1%
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
0.22
84th pctl of 33 SIC 7372 peers (best = lowest)
Current ratio
5.46×
92nd pctl of 38 SIC 7372 peers
Quick ratio
5.32×
Net cash
$7.24B
Cash & equivalents minus total debt.
Cash-flow health
Free cash flow
—
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
—
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
14.8%
Stock-based comp intensity.
Piotroski F-Score
F-Score
5 / 9
Fundamental-strength score (0-9).